Jpmorgan Chase & Co »

Celldex Therapeutics Inc New put shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Celldex Therapeutics Inc New put shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Celldex Therapeutics Inc New put

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics Inc New put held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics Inc New put by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $299k 8.8k 33.99
2024-06-30 $326k 8.8k 37.01
2024-03-31 $369k 8.8k 41.97
2021-12-31 $5.4M 141k 38.64

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Celldex Therapeutics Inc New put

Simplex Trading
Group One Trading
Jpmorgan Chase & Co

View all funds holding Celldex Therapeutics Inc New put